Advertisement
FALLS CHURCH, Va., Oct. 18, 2018 /PRNewswire-PRWeb/ -- Brexit and the Impact to Your Global Business Operations: What Life Sciences Companies Need to Know Now **An FDAnews Webinar** Nov. 1, 2018 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/brexitimpactglblbusops
When Britain exits the EU, what happens?
The EMA is moving to from London to Amsterdam in March 2019 and will lose 30 percent of its staff. The agency has already stopped accepting and publishing clinical trials data.
What about the legal uncertainty regarding contracts involving both the UK and other EU member states?
Brexit is about to happen and drug and devicemakers need to make plans before it does. Prepare to discover:
Meet the Presenter Michael Burke, Partner, Corporate Practice, Arnall Golden Gregory
Michael Burke provides practical and actionable legal and compliance guidance that allows companies to focus on business growth. He helps companies minimize risk and maximize return across a wide range of domestic and cross-border corporate and commercial transactions and regulatory issues. Mike is a partner in the Corporate Practice and co-chairs Arnall Golden Gregory's Pharmaceuticals and Medical Devices Industry Team. Mike co-chairs the American Bar Association-United Nations Development Programme International Legal Resource Center and is the immediate past chair of the American Bar Association's Section Officer's Conference.
Who Will Benefit Any quality or regulatory professional at a life sciences company with operations involving the European Union and the United Kingdom including:
Tuition: $287 per site
Easy Ways to Register: Online: http://www.fdanews.com/brexitimpactglblbusops By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDANEWS
Advertisement
When Britain exits the EU, what happens?
The EMA is moving to from London to Amsterdam in March 2019 and will lose 30 percent of its staff. The agency has already stopped accepting and publishing clinical trials data.
What about the legal uncertainty regarding contracts involving both the UK and other EU member states?
Brexit is about to happen and drug and devicemakers need to make plans before it does. Prepare to discover:
- The impact on international harmonization efforts: The EMA will "only take a reactive role," focus on "urgent" drug safety guidelines and limit travel to "Brexit-related interactions."
- How to deal with the legal uncertainty introduced into contracts involving both the UK and EU member states
- And much more…
Meet the Presenter Michael Burke, Partner, Corporate Practice, Arnall Golden Gregory
Michael Burke provides practical and actionable legal and compliance guidance that allows companies to focus on business growth. He helps companies minimize risk and maximize return across a wide range of domestic and cross-border corporate and commercial transactions and regulatory issues. Mike is a partner in the Corporate Practice and co-chairs Arnall Golden Gregory's Pharmaceuticals and Medical Devices Industry Team. Mike co-chairs the American Bar Association-United Nations Development Programme International Legal Resource Center and is the immediate past chair of the American Bar Association's Section Officer's Conference.
Who Will Benefit Any quality or regulatory professional at a life sciences company with operations involving the European Union and the United Kingdom including:
- President
- Vice President
- Operations Managers
- Supplier Managers
- Regulatory Affairs
- Quality Assurance
Tuition: $287 per site
Easy Ways to Register: Online: http://www.fdanews.com/brexitimpactglblbusops By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDANEWS
